Clinical Trials
4 trialsNCT01156584 2018-05-21
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
Tocagen Inc.
Phase 1 Completed
NCT01470794 2018-05-21
Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Tocagen Inc.
Phase 1 Completed
NCT01985256 2018-05-21
Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Tocagen Inc.
Phase 1 Completed
NCT00978107 2014-07-16
Trial of TG4023 Combined With Flucytosine in Liver Tumors
Transgene
Phase 1 Completed